Close Menu

NEW YORK (GenomeWeb) – Abbott said Wednesday that its fourth quarter diagnostic revenues grew 3 percent year over year on a reported basis and 7 percent on an organic basis to $1.96 billion from $1.91 billion in the year-ago period.

For the three months ended Dec. 31, 2018, Abbott reported worldwide revenues of $7.77 billion, up 2 percent from $7.59 billion a year ago, but lower than the average Wall Street estimate of $7.82 billion. Sales increased 6 percent year over year on an organic basis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.